1α,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 2, 1999, Pages 120-128

  Yudoh, Kazuo ^a   Matsuno, Hiroaki ^b   Kimura, Tomoatsu ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM; COLECALCIFEROL; COLLAGEN; DNA;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; BODY WEIGHT; C57BL MOUSE; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL MOTION; DRUG EFFECT; EXPERIMENTAL MELANOMA; EXTRACELLULAR MATRIX; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; SKIN TUMOR;

ANIMALS; BODY WEIGHT; CALCIUM; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CHOLECALCIFEROL; COLLAGEN; DNA, NEOPLASM; EXTRACELLULAR MATRIX; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, CALCITRIOL; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033068144     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90004-5     Document Type: Article

References (34)

1. 1. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988;37:889-95.
2. 2. Norman AW, Zhou JY, Henry HL, Uskokovie MR, Koeffler HP. Structure-function studies on analogues of 1α, 25 dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 1990;50:6857-64.
3. 3. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D3 endocrine system in health and disease. N Engl J Med 1991;320:980-91.
4. 4. Frampton RJ, Omind SA, Eisman JA. Inhibition of human cancer cell growth by 1,25 dihydroxyvitamin D3 metabolites. Cancer Res 1983;43:4443-7.
5. 5. Bikle DD. Clinical counterpoint. Vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev 1992;13:765-84.
6. 6. Wang X, Gardner JP, Kheir A, Uskokovic MR, Studzinski GP. Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst 1997;86:1199-206.
7. 7. Sato T, Takusagawa K, Asso N, Konno K. Effect of 1α-dihydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231. Br J Cancer 1984;50:123-5.
8. 8. Thompson EW, Paik S, Bruner N. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992;150:534-44.
9. 9. Mørk Hansen C, Frandsen TL, Frandsen TL, Brunner N, Binderup L. 1α, 25 dihydroxy vitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 1994;12:195-202.
10. 10. Volk T, Geiger B, Raz A. Motility and adhesive properties of high-and low-metastatic neoplastic cells. Cancer Res 1984;44:811-24.
11. 11. Liotta LA. Tumor invasion and metastases: role of the extracellular matrix. Rohoads Memorial Award Lecture. Cancer Res 1986;46:1-7.
12. 12. Kanata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinoma in culture. Cancer Res 1986;46:1648-53.
13. 13. Sand T-E, Brønstad G, Digernes V, Killi A, Amara W, Refsnes M, et al. Quantitative aspects of the effects of insulin, epidermal growth factor and dexamethasone on DNA synthesis in cultured adult rat hepatocytes. Acta Endocrinol 1987;109:369-77.
14. 14. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
15. 15. Voldavsky I, Ariav Y, Atzmon R, Fukus Z. Tumor cell attachment to the vascular endothelial extracellular matrix. Exp Cell Res 1982;140:1982.
16. 16. Yudoh K, Matsui H, Kanamori H, Ohmori K, Tsuji H. Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clones of murine RCT sarcoma in vitro. Jpn J Cancer Res 1995;86:685-90.
17. 17. Nakajima M, Welch DR, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987;47:4869-76.
18. 18. Yoneda J, Sasaki I, Fujii H, Abe F, KojimaY, Azuma I. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin). Clin Exp Metastasis 1992;10:49-59.
19. 19. Bar-Shavit Z, Kahm AJ, Stone KR, Trial J, Hilliard T, Reitsma PH, et al. Reversibility of vitamin D-induced human leukemia cell-line maturation. Endocrinology 1986;118:679-86.
20. 20. Gerstenfeld LC, Kelly CM, von Deck M, Lian JB. Effect of 1, 25 dihydroxyvitamin D3 induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 199;20:1599-609.
21. 21. Kreutz M, Andreesen R. Induction of human monocyte to macrophage maturation in vitro by 1, 25-dihydroxyvitamin D3. Blood 1990;76:2457-61.
22. 22. Binderup L. Immunological properties of vitamin D analogues and metabolites. Biochem Pharmacol 1992;43:1885-92.
23. 23. Brackman D. Effects of 1,25-dihydroxyvitamin D3 on transformed CH3/10T1/2 fibroblasts growth as multicellular spheroids. Int J Cancer 1995;62:428-35.
24. 24. Welsh J, Simboli-Campbell M, Narvaez CJ, Tenniswood M. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol 1995;375:45-52.
25. 25. Narvaez CJ, Vanweelden K, Byrne I, Welsh J. Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology 1996;137:400-9.
26. 26. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992;41:231-40.
27. 27. Kobayashi H, Ohi H, Shinohara H, Sugimura M, Fujii T, Terao T, et al. Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion. Br J Cancer 1993;67:537-44.
28. 28. Koli K, Keski-Oja J. Vitamin D3 and calicipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes. J Invest Dermatol 1993;101:706-12.
29. 29. de Vries JE, Dinjens WN, De Bruyne GK, Verspaget HW, van der Linden EP, de Bruine AP, et al. In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells. Br J Cancer 1995;71:271-7.
30. 30. Krupitza G, Grill S, Harant H, Hulla W, Szekeres T, Huber H, et al. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian. Br J Cancer 1996;73:433-8.
31. 31. Brackman D, Trydal T, Lillehaug JR, Aarskog D. Reorganization of the cytoskeleton and morphological changes induced by 1,25-dihydroxyvitamin D3 in C3H/10T1/2 mouse embryo fibroblasts: relation to inhibition of proliferation. Exp Cell Res 1992;201:485-93.
32. 32. Boyan BD, Dean DD, Sylvia VL, Schwarrtz Z. Nongenomic regulation of extracellular matrix events by vitamin D metabolites. J Cell Biochem 1994;56:331-9.
33. 33. Felding-Habermann B, Cheresh DA. Vitronectin and its receptor. Curr Opin Cell Biol 1993;5:864-8.
34. 34. Brooks PC, Stomblad S, Samders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996;85:683-93.